Workplace safety is an important aspect to protect personnel against injury or serious accident.In case of animal cell culture safety takes a front seat due to nature of work i.e. handling of human cells and tissues, viruses with high potential to cause infections to humans and other adventitious micro organisms. This presentation presents various methods of safety to protect lab personnel from infectious biological agents.
A lecture for first-year students at Baquba Technical Institute belongs to Middle Technical University. This lecture is a part of the first semester's modules (Medical Laboratory Technology: MLT112).
This lecture included an introduction to medical (or diagnostic) laboratories.
Responsibilities of Clinical Laboratory Scientist and TechniciansBest care Lab
Laboratory science, being the vital element of the medical industry, a medical laboratory and its technicians play a great role in it. In general medical laboratory scientists and medical laboratory technicians collect samples and perform the tests to analyze body fluids, tissue, and other substances.
This slide is all about the hematopoeitic stem cells its two types myeloid and lymphoid. The different types of myleoid and lymphoid cells are explained in details. All details about different White Blood Cells and their function. B cell, T cell and Natural Killer cell and their function.
Interpretative lab reports having test specific comments & notes is becoming a need & tool for clinical interface. Various quality guidelines have also included interpretative & advisory services as part of checklist & scope for laboratory accreditation. However, every laboratory needs to strategize methodology along with its LIMS, ways for implementation.
Workplace safety is an important aspect to protect personnel against injury or serious accident.In case of animal cell culture safety takes a front seat due to nature of work i.e. handling of human cells and tissues, viruses with high potential to cause infections to humans and other adventitious micro organisms. This presentation presents various methods of safety to protect lab personnel from infectious biological agents.
A lecture for first-year students at Baquba Technical Institute belongs to Middle Technical University. This lecture is a part of the first semester's modules (Medical Laboratory Technology: MLT112).
This lecture included an introduction to medical (or diagnostic) laboratories.
Responsibilities of Clinical Laboratory Scientist and TechniciansBest care Lab
Laboratory science, being the vital element of the medical industry, a medical laboratory and its technicians play a great role in it. In general medical laboratory scientists and medical laboratory technicians collect samples and perform the tests to analyze body fluids, tissue, and other substances.
This slide is all about the hematopoeitic stem cells its two types myeloid and lymphoid. The different types of myleoid and lymphoid cells are explained in details. All details about different White Blood Cells and their function. B cell, T cell and Natural Killer cell and their function.
Interpretative lab reports having test specific comments & notes is becoming a need & tool for clinical interface. Various quality guidelines have also included interpretative & advisory services as part of checklist & scope for laboratory accreditation. However, every laboratory needs to strategize methodology along with its LIMS, ways for implementation.
ExL Pharma Clinical Trials Phase I and Phase IIa Conference Brochure: Phase 1...bryonmain
There is a pill or treatment for almost everything, or at least, that is how it seems. However, the amount of effort that goes into a pill or treatment before it is launched is extensive, expensive and often inefficient.
Efficiency and innovation go hand-in-hand with R&D and the development of clinical trials, however, FDA regulations and clinical trial standardization end up stifling these two key factors. This leads to drawn out processes that cost companies hundreds of millions of dollars before the drugs hit the market. Efforts have been made to increase efficiency in phase I/IIA with some companies changing their clinical trial manifestos to suit the available patient population at clinical sites, but more emphasis should be placed on creating more efficient processes for first in human studies by optimizing pharmacokinetics/pharmacodynamics, dosage selection, technological advancements to improve efficacy and structured patient mapping to increase successful trial and patient recruitment opportunities.
This program will give delegates the opportunity to share proven strategies between companies to help increase efficiency in this space and streamline processes to cut down costs. This event will bring together large and small companies and experts in this space to share best practices to decrease the financial drain theses phases have on the overall clinical trial budget. Life science corporations need the most up-to-date tools and practices to increase success by streamlining processes, sharing successful biomarker strategies, anticipating dosing quantities, and optimizing healthy or specialty patient recruitment and retention. Current strategies include patient mapping before organizing and setting up a clinical space, tailoring early phase clinical trials to patient populations, purchasing biological samples from collection companies, and trying to accelerate the process by submitting for breakthrough therapy designation.
Top Reasons To Attend
Identify Compound Development Strategies to Optimize Success in Clinical Trials
Learn Best Practices for Early Decision-Making Through Analysis of Biomarker Utility in Drug Development
Utilize Analytical Technology to Evaluate Multiple Configurations of a Small Molecule to Increase the Feasibility of Drug in Clinical Trials
Implement Adaptive Design in Proof of Concept Studies to Increase Efficiency, Decrease Time and Decrease Overall Cost
Explore the Seamless Development of Phase I to Phase II in Clinical Trials
NINE Case Studies and a Panel Session on Early Phase Clinical Trial Strategies
This presentation by Morris Kleiner (University of Minnesota), was made during the discussion “Competition and Regulation in Professions and Occupations” held at the Working Party No. 2 on Competition and Regulation on 10 June 2024. More papers and presentations on the topic can be found out at oe.cd/crps.
This presentation was uploaded with the author’s consent.
0x01 - Newton's Third Law: Static vs. Dynamic AbusersOWASP Beja
f you offer a service on the web, odds are that someone will abuse it. Be it an API, a SaaS, a PaaS, or even a static website, someone somewhere will try to figure out a way to use it to their own needs. In this talk we'll compare measures that are effective against static attackers and how to battle a dynamic attacker who adapts to your counter-measures.
About the Speaker
===============
Diogo Sousa, Engineering Manager @ Canonical
An opinionated individual with an interest in cryptography and its intersection with secure software development.
Acorn Recovery: Restore IT infra within minutesIP ServerOne
Introducing Acorn Recovery as a Service, a simple, fast, and secure managed disaster recovery (DRaaS) by IP ServerOne. A DR solution that helps restore your IT infra within minutes.
Sharpen existing tools or get a new toolbox? Contemporary cluster initiatives...Orkestra
UIIN Conference, Madrid, 27-29 May 2024
James Wilson, Orkestra and Deusto Business School
Emily Wise, Lund University
Madeline Smith, The Glasgow School of Art
Have you ever wondered how search works while visiting an e-commerce site, internal website, or searching through other types of online resources? Look no further than this informative session on the ways that taxonomies help end-users navigate the internet! Hear from taxonomists and other information professionals who have first-hand experience creating and working with taxonomies that aid in navigation, search, and discovery across a range of disciplines.
The Future of Laboratory Medicine: Understanding the New Coercions
1. The Future of Laboratory
Medicine: Understanding
the New Coercions
MAURO PANTEGHINI'S
Verunque, Crez Caye L.
BMLS 1-B
2. Because of advances in
technology, medical
technology has evolved at a
rapid pace.
In the recent history, numerous unfamiliar
diagnostic methods and laboratory tests have been
introduced as a result of both investigation on the
abecedarian pathogenesis of conditions and the
development of new techniques in themselves.
3. Clinical laboratories
represent an area of
healthcare that has always
undergone major changes
because of technological
advances and external
economic pressures.
5. vigorously and diversely challenged by
economic and current technological
pressures
take a broad view of the discipline
present to the directors the full
diapason of conditioning and benefits
Laboratory Medicine can give.
The future purpose of Laboratory
Medicine
It is essential to:
6. Undergoing a Paradigm Shift
Laboratories are easy prey for
profitable confinements and
limitations due to their
technological characteristics.
7. practice guideline formulation,
laboratory service restructuring, and
patient satisfaction measurement.
Understanding laboratory-related
outcomes permits the laboratory to
contribute in institutional quality
management including such:
1.
2.
3.
Outcome of Laboratory Practices
9. Promoting the Laboratory-
Clinic Interface
ensure that the patient is
given high quality care
provides the boundary for
the multidisciplinary
activities
10. Three strategies have been recommended for
supporting and promoting clinical consultancy
in Laboratory Medicine:
1. use of reflex testing and algorithms;
2. providing interpretative comments; and
3. organisation of clinical audits.1
11. The increasing complexity of the health-care
environment, as well as the availability of an
ever-expanding array of laboratory tests, has
emphasized the demand for greater integration
of clinical and laboratory data.
Conclusion
12. References
Plebani M. Charting the course of medical laboratories in a
changing environment. Clin Chim Acta. 2002;319:87–100
Bissell MG. Introduction: what’s in a laboratory outcome? In:
Bissell MG editor. Laboratory-related measures of patient
outcomes: An introduction, AACC Press, Washington; 2000. pp.
3–10.
Marques MB, McDonald JM. Defining/measuring the value of
clinical information. Clin Leadersh Manag Rev. 2000;14:275–9.